NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,139 filers reported holding NOVARTIS A G in Q4 2021. The put-call ratio across all filers is 0.26 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $518 | +41.5% | 5,090 | +40.5% | 0.04% | +50.0% |
| Q2 2023 | $366 | +9.9% | 3,623 | 0.0% | 0.03% | +3.7% |
| Q1 2023 | $333 | 0.0% | 3,623 | -1.4% | 0.03% | -3.6% |
| Q4 2022 | $333 | -99.9% | 3,675 | +14.0% | 0.03% | +21.7% |
| Q3 2022 | $245,000 | -14.9% | 3,225 | -5.3% | 0.02% | -8.0% |
| Q2 2022 | $288,000 | -3.7% | 3,405 | 0.0% | 0.02% | +8.7% |
| Q1 2022 | $299,000 | -18.8% | 3,405 | -19.0% | 0.02% | -20.7% |
| Q4 2021 | $368,000 | -34.4% | 4,204 | -38.7% | 0.03% | -38.3% |
| Q3 2021 | $561,000 | +1.8% | 6,854 | +13.5% | 0.05% | +2.2% |
| Q2 2021 | $551,000 | +1.3% | 6,041 | -5.0% | 0.05% | +2.2% |
| Q1 2021 | $544,000 | +149.5% | 6,359 | +187.1% | 0.04% | -6.2% |
| Q1 2015 | $218,000 | +6.3% | 2,215 | 0.0% | 0.05% | +4.3% |
| Q4 2014 | $205,000 | +2.5% | 2,215 | +4.0% | 0.05% | 0.0% |
| Q3 2014 | $200,000 | 0.0% | 2,130 | -3.6% | 0.05% | 0.0% |
| Q2 2014 | $200,000 | – | 2,210 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EXENCIAL WEALTH ADVISORS, LLC | 188,514 | $13,713,000 | 5.95% |
| PRENTISS SMITH & CO INC | 136,441 | $10,133,000 | 5.74% |
| MANAGED ASSET PORTFOLIOS, LLC | 204,985 | $15,225,000 | 5.46% |
| Osher Van de Voorde Investment Management | 108,725 | $8,075,000 | 4.40% |
| BROWN BROTHERS HARRIMAN & CO | 10,796,684 | $801,870,000 | 4.35% |
| SECTORAL ASSET MANAGEMENT INC | 472,296 | $35,077,000 | 4.10% |
| PROFESSIONAL ADVISORY SERVICES INC | 235,347 | $17,479,000 | 3.87% |
| Elefante Mark B | 5,619 | $417,000 | 3.78% |
| SPHERA FUNDS MANAGEMENT LTD. | 255,000 | $18,959,000 | 3.71% |
| CGOV Asset Management | 997,161 | $98,662,000 | 3.61% |